Why the study?
Antidepressant treatment often lasts too long due to absent specific deprescription guidelines, and evidence is needed on safety profiles, switching methods, and deprescribing.
Provides guidance on the safe prescribing, switching, and deprescribing of antidepressants to optimize pharmacotherapy and prevent unnecessarily prolonged treatment.
Answers are grounded in this paper and cite their sources.
Provides deprescribing and switching protocols for antidepressants; extends practical guidance amid rising long-term use.
INTRODUCTION Antidepressant use has increased over the past few years. Given the lack of evidence concerning differences in efficacy between the various antidepressants, it is important to understand the safety profile to ensure the safe use thereof. Antidepressant treatment typically lasts for too long, partly due to the absence of specific deprescription guidelines. An understanding of the best methods for switching between antidepressants, and the most suitable methods for deprescribing, may help to optimise the pharmacotherapy of depression. OBJECTIVES To establish suitable guidelines for the prescribing, switching, use and deprescribing of antidepressants. METHODS A search was carried out for clinical practice guidelines, systematic reviews and bulletins to compile the evidence available regarding the correct use and deprescribing of antidepressants. The prescription database of the Servicio Navarro de Salud-Osasunbidea (SNS-O) [Navarre Health Service] was used to obtain data regarding antidepressant use in Navarre. CONCLUSIONS When planning the treatment of depression it is necessary to consider, initially, whether the prescription of an antidepressant drug is actually indicated in that specific situation. Secondly, it is crucial to think about the characteristics and comorbidities of the patient when selecting the most appropriate drug. In this regard, before adding a new drug, pharmacotherapy must be optimised by increasing the dose, waiting for the appropriate amount of time and considering switching to another antidepressant. Finally, treatment must be reassessed periodically considering that such treatments are not for life and withdrawal of the drug gradually and with the patient’s consent should be evaluated to increase the likelihood of a successful withdrawal
No takes yet. Share an insight, caveat, or question.
Oihane Goñi (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: